Skip Nav Destination
First Edition
Research Article October 17 2024
Access Barriers to Anti-CD19+ CART-Cell Therapy for NHL Across a Community Transplant and Cellular Therapy Network
Minoo Battiwalla,Michael T Tees,Ian W. Flinn,Jeremy Pantin,Jesus G. Berdeja,Tara Gregory,Michael B Maris,Vikas Bhushan,Estil Vance, M.D.,John Mathews,Carlos Bachier,Paul J Shaughnessy,Aravind Ramakrishnan,Shahbaz A. Malik,Shahram Mori,Casey Martin,Rocky Billups,Betsy Blunk,Charles F LeMaistre,Navneet S Majhail
Review Article October 17 2024
Induction of factor VIII tolerance by hemophilia gene transfer to eradicate factor VIII inhibitors
Research Article October 17 2024
Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemia
Romane Joudinaud,Augustin Boudry,Laurène Fenwarth,Sandrine Geffroy,Mikaël Salson,Hervé Dombret,Celine Berthon,Arnaud Pigneux,Delphine Lebon,Pierre Peterlin,Simon Bouzy,Pascale Flandrin-gresta,Emmanuelle Tavernier,Martin Carre,Sylvie Tondeur,Lamya Haddaoui,Raphaël A. Itzykson,Sarah Bertoli,Audrey Bidet,Eric Delabesse,Mathilde Hunault,Christan Récher,Claude Preudhomme,Nicolas Duployez,Pierre-yves Dumas
Research Article October 10 2024
AML typical mutations (CEBPA, FLT3, and NPM1) identify a high-risk CMML independent of CPSS-Mol classification
Sandra Castaño-Díez,Mònica López-Guerra,Inés Zugasti,Xavier Calvo,Felicitas Isabel Schulz,Alejandro Avendaño,Elvira Mora,Jose Francisco Falantes-González,Gemma Azaceta,Mariam Ibañez,Tzu-Hua Chen-Liang,Cristina Notario Mc Donnell,Neus Amer-Salas,Laura Palomo,Helena Pomares,Jordi Vila,Teresa Bernal del Castillo,Carlos Jiménez-Vicente,Daniel Esteban,Francesca Guijarro,José Ramón Álamo Moreno,Albert Cortés-Bullich,Víctor Torrecillas-Mayayo,Ana Triguero,Lucía Mont-de Torres,Ester Carcelero,Aina Cardús,Ulrich Germing,Beate Betz,Maria Rozman,Leonor Arenillas,Lurdes Zamora,María Díez-Campelo,Blanca Xicoy,Jordi Esteve,Marina Díaz-Beyá
Letter October 9 2024
Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival
Review Article October 8 2024
Factor XI inhibitors: a new class of anticoagulants
Research Article October 7 2024
Maintenance of hematopoietic stem cells by tyrosine-unphosphorylated STAT5 and JAK inhibition
Matthew J Williams,Xiaonan Wang,Hugo P Bastos,Gabriela Grondys-Kotarba,Qin Wu,Shucheng Jin,Carys S Johnson,Nicole Mende,Emily Francesca Calderbank,Michelle Wantoch,Hyun Jung Park,Giovanna Mantica,Rebecca Louise Hannah,Nicola K Wilson,Dean C Pask,Tina L Hamilton,Sarah J Kinston,Ryan Asby,Rachel Sneade,E. Joanna Baxter,Peter J Campbell,George S Vassiliou,Elisa Laurenti, PhD,Juan Li,Berthold Gottgens,Anthony R Green
Letter October 7 2024
Acquired BCL2 variants associated with venetoclax resistance in acute myeloid leukemia
Research Article October 4 2024
A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT
Research Article October 4 2024
The common, VTE-protective, G haplotype of F5 increases factor V-short, TFPI function, and risk of bleeding
Matthew Christopher Sims,Magdalena Gierula,Jonathan C. Stephens,Alex Tokolyi,Luca Stefanucci,Elodie Persyn,Luanluan Sun,Janine H Collins,Emma Davenport,Emanuele Di Angelantonio,Kate Downes,Michael Inouye,Dirk S Paul,William Thomas,Alexander Tolios,NIHR BioResource,Willem H Ouwehand,Nicholas S Gleadall,James T.B. Crawley,Adam S Butterworth,Mattia Frontini,Josefin Ahnstrom
Research Article September 30 2024
CD37 in acute myeloid leukemia: a novel surface target for drug delivery
Erin Jeremy,Esthela Artiga,Sara Elgamal,Carolyn M Cheney,Dalen Eicher,Kevan Zalponik,Shelley Orwick,Hsiao-Yin Charlene Charlene Mao,Ronni Wasmuth,Bonnie K Harrington,Allison Mustonen,Peter Beshay,Patrick Halley,Carlos Castro,Katie E Williams,Zachary A Hing,Timothy L Chen,Christopher R Lucas,Nicholas J Vantangoli,Rosa Lapalombella,Nicole Renee Grieselhuber,Xiaokui M. Mo,Erin Hertlein,Natarajan Muthusamy,Bethany L Mundy-Bosse,John C. Byrd,Karilyn Larkin
Research Article September 26 2024
EASIX and m-EASIX Predict CRS and ICANS in Pediatric and AYA Patients post CD19-CAR T cell Therapy
Letter September 24 2024
Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis
Paul G Kemps,F.J. Sherida H. Woei-A-Jin,Koen D. Quint,Cor van den Bos,Leonie Naeije,Jan AM van Laar,Isabelle Vanden Bempt,Marco J. Koudijs,Ruben Harmen Paul Vorderman,Ellen Stelloo,Joost F Swennenhuis,Annette H Bruggink,Konnie M. Hebeda,Marijn A. Scheijde-Vermeulen,Gilles FH Diercks,Robert M. Verdijk,Patty M Jansen,Esther Hauben,Thomas Tousseyn,Arjen HG Cleven,Tom van Wezel,Astrid G.S. van Halteren,Pancras C.W. Hogendoorn
Research Article September 18 2024
Venetoclax-based salvage therapy as bridge-to-transplant is feasible and effective in patients with relapsed/refractory AML
Research Article September 18 2024
Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5' RACE
Vincent Camus,Mathieu Viennot,Pierre-Julien Viailly,Fanny Drieux,Elena-Liana Veresezan,Victor Bobée,Vinciane Rainville,Elodie Bohers,Pierre Sesques,Corinne Haioun,Eric Durot,Michael Bayaram,Cédric Rossi,Laurent Martin,Dominique Penther,Sophie Kaltenbach,Julie Bruneau,Jérôme Paillassa,Olivier Tournilhac,Nicolas Gower,Alexandre Willaume,Chloe Antier,Loïc Renaud,Emilie Leveque,Pierre Decazes,Stéphanie Becker,David Tonnelet,Philippe GAULARD,Hervé Tilly,Thierry Molina,Alexandra Traverse-Glehen,Marie Donzel,Philippe Ruminy,Fabrice Jardin
Letter August 20 2024
Tolerability & long-term disease control by IGHV mutation status among CLL patients on ibrutinib arm of E1912
Tait D. Shanafelt,Xin Victoria Wang,Curtis A. Hanson,Elisabeth Paietta,Susan M. O'Brien, M.D.,Jacqueline Claudia Barrientos,Diane F Jelinek,Esteban Braggio,Jose F. Leis,cong zhang,Paul M. Barr,Amanda F Cashen,Anthony R Mato,Avina K Singh,Michael Mullane,Richard F. Little,Harry P. Erba,Richard M. Stone,Mark R Litzow,Martin S. Tallman,Neil E. Kay
Research Article August 12 2024
